Healthcare Facilities company Healthcare Global Enterprises announced Q1FY25 results: Financial Highlights: Revenue: Rs 5,256 million, +14% YoY Adjusted EBITDA: Rs 929 million, +21% YoY PAT: Rs 121 million, +59% YoY Operational Highlights: Overall ARPOB stood at Rs 44,342 vs. Rs 39,686 in Q1FY24, a growth of 12% Overall AOR stood at 65.7% vs. 66.9% in Q1FY24 RoCE for Established centers stood at 14.1% vs. 15.5% in Q1FY24. RoCE pre-corporate allocations stands at 17.4% RoCE for Emerging centers stood at -9.3% vs. -15.2% in Q1FY24. RoCE pre-corporate allocations stands at -6.1% Kolkata grew by 73% for the quarter on a YoY basis Nagpur, South Mumbai, Nashik & Bhavnagar grew by 26%, 22%, 22% and 21% YoY respectively Commenting on the results, B.S. Ajaikumar, Executive Chairman, HealthCare Global Enterprises said, “As planned, we continue to deliver strong financials as well as operational excellence across the network. Our centers are performing as expected or even better. During the quarter, we expanded our footprint and portfolio by virtue of the acquisition of Vizag-based Mahatma Gandhi Cancer Hospital and Research Institute. Going forward, Vizag will undoubtedly play a key role in shaping our growth strides. Having already established a strong brand in the region, we will in good time consolidate our presence to become the single largest player in the region. Given our ethos of pursuing excellence as a continuum, our doctors, specialists, and clinicians remain unflinchingly focused on disruptive innovation by virtue of academics and research, which translates into novel therapies and breakthroughs enhancing the quality of life and outcomes for our patients. Thanks to our unique approach of providing our patients with the right treatment at the right time, our outcomes are comparable to those of leading cancer care institutions worldwide. As we move forward, our commitment to providing innovation-focused, technologyenabled, value-based cancer care will help us expand our reach to serve more communities across new geographies. I am immensely proud of Team HCG; it is the collective effort of every HCGian that has helped us serve the larger cause of our ultimate stakeholders, our patients, with conviction and credence and, in the process, has seen us carve a niche as a destination for cancer care in the country.” Raj Gore, CEO HealthCare Global Enterprises added, “We are pleased to announce that our revenue for the quarter has increased by 16.7% year-over-year excluding revenues from discontinued MSR operations. Our EBITDA grew by 22.3% year-over-year, demonstrating significant operational leverage in our business. The EBITDA margin for Q1 was 17.3%, a 120 bps increase year-over-year, continuing the upward trend we have observed in recent quarters and remain optimistic about further improvements. Our consistent revenue growth is driven by volume increases across modalities and enhanced operational performance, supported by the strong results of our established centers and the progress in our emerging centers. We have been diligently working to turn around operations at our emerging centers, and we are excited to report that our Kolkata center has shown promising growth and is now contributing to our overall EBITDA. We are confident that the emerging centers will see revenue growth and margin expansion over the next 12 months, significantly contributing to overall margins. As we reflect on this quarter, we are inspired by the dedication and hard work of our entire team. Our focus on delivering exceptional cancer care and expanding our network continues to drive our success. With the momentum from our recent acquisition and the ongoing support of our partners, we are well-positioned for sustained growth and innovation. We look forward to building on this strong foundation as we continue our mission to improve patient outcomes and set new standards in cancer treatment.” Result PDF